ERBB2 and breast carcinoma: In contrast, the two studies that included women treated within Kaiser Permanente’s integrated healthcare system or within an equal-access military treatment facility of the Department of Defense found no significant difference in survival between Black and White women with HR+/HER2-breast cancer [18,19].